ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0470
+0.0100 (27.03%)
Oct 2, 2025, 4:10 PM AEST
ImpediMed Market Cap
ImpediMed has a market cap or net worth of 95.70 million as of October 2, 2025. Its market cap has decreased by -3.46% in one year.
Market Cap
95.70M
Enterprise Value
88.01M
Revenue
12.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since October 24, 2007, ImpediMed's market cap has increased from 67.49M to 95.70M, an increase of 41.79%. That is a compound annual growth rate of 1.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 95.70M | -9.09% |
| Dec 31, 2024 | 105.26M | -64.12% |
| Dec 29, 2023 | 293.38M | 108.23% |
| Dec 30, 2022 | 140.90M | -54.66% |
| Dec 31, 2021 | 310.77M | 130.93% |
| Dec 31, 2020 | 134.57M | 60.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 95.86B |
| Pro Medicus | 32.22B |
| Cochlear | 18.27B |
| Sonic Healthcare | 10.60B |
| Ramsay Health Care | 7.30B |
| Telix Pharmaceuticals | 4.93B |
| Ansell | 4.59B |
| Mesoblast | 3.03B |